-
公开(公告)号：US10831169B2
公开(公告)日：2020-11-10
申请号：US16447352
申请日：2019-06-20
IPC分类号： G06F17/00 , G06G7/48 , G06Q10/00 , G05B13/02 , G05B19/418 , G05B19/048 , G05B19/4063
摘要： The present disclosure relates to a manufacturing system, method and control circuitry for quality assured manufacturing of at least two biopharmaceutical products. The manufacturing system comprises a warehouse facility, a hydration facility, and at least two biopharmaceutical manufacturing facilities, wherein the warehouse facility and hydration facility are comprised in the macro structure. Each biopharmaceutical manufacturing facility is comprised in a respective micro node, and a control facility in the macro structure is configured to control interoperability of the macro structure and the micro nodes by means of a network spine interconnecting the macro structure with each micro node.
-
公开(公告)号：US20190302720A1
公开(公告)日：2019-10-03
申请号：US16447352
申请日：2019-06-20
IPC分类号： G05B19/048 , G05B19/418 , G05B19/4063
摘要： The present disclosure relates to a manufacturing system, method and control circuitry for quality assured manufacturing of at least two biopharmaceutical products. The manufacturing system comprises a warehouse facility, a hydration facility, and at least two biopharmaceutical manufacturing facilities, wherein the warehouse facility and hydration facility are comprised in the macro structure. Each biopharmaceutical manufacturing facility is comprised in a respective micro node, and a control facility in the macro structure is configured to control interoperability of the macro structure and the micro nodes by means of a network spine interconnecting the macro structure with each micro node.
-
公开(公告)号：US10372100B2
公开(公告)日：2019-08-06
申请号：US15249982
申请日：2016-08-29
IPC分类号： A61K39/395 , C07K16/24 , A61K39/00 , A61K47/18 , G05B19/048 , G05B19/4063 , G05B19/418
摘要： The present disclosure relates to a manufacturing system, method and control circuitry for quality assured manufacturing of at least two biopharmaceutical products. The manufacturing system comprises a warehouse facility, a hydration facility, and at least two biopharmaceutical manufacturing facilities, wherein the warehouse facility and hydration facility are comprised in the macro structure. Each biopharmaceutical manufacturing facility is comprised in a respective micro node, and a control facility in the macro structure is configured to control interoperability of the macro structure and the micro nodes by means of a network spine interconnecting the macro structure with each micro node.
-
公开(公告)号：US20180059632A1
公开(公告)日：2018-03-01
申请号：US15249982
申请日：2016-08-29
IPC分类号： G05B19/048 , G05B19/4063
CPC分类号： G05B19/048 , G05B19/4063 , G05B19/41845 , G05B19/4188 , G05B2219/31011 , G05B2219/31268 , G05B2219/32368 , G05B2219/32388 , G05B2219/32393 , Y02P90/16 , Y02P90/18 , Y02P90/22 , Y02P90/24 , Y02P90/28 , Y02P90/285
摘要： The present disclosure relates to a manufacturing system, method and control circuitry for quality assured manufacturing of at least two biopharmaceutical products. The manufacturing system (100) comprises a warehouse facility (210), a hydration facility (220), and at least two biopharmaceutical manufacturing facilities, wherein the warehouse facility (210) and hydration facility (220) are comprised in the macro structure (200). Each biopharmaceutical manufacturing facility is comprised in a respective micro node (300), and a control facility (230) in the macro structure (200) is configured to control interoperability of the macro structure (200) and the micro nodes (300) by means of a network spine interconnecting the macro structure (200) with each micro node (300).
-
-
-
搜索结果
4 条记录 (耗时 0.014 秒)
